Cargando…

Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?

SIMPLE SUMMARY: Chronic active Epstein–Barr virus (EBV) infection (CAEBV) is a rare syndrome of unknown etiology characterized by prolonged infectious mononucleosis-like symptoms and proliferation of EBV-infected T and/or natural killer cells. CAEBV has been primarily reported in East Asia and Latin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Shigeyoshi, Nakamura, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692233/
https://www.ncbi.nlm.nih.gov/pubmed/33143184
http://dx.doi.org/10.3390/cancers12113202
_version_ 1783614464618135552
author Fujiwara, Shigeyoshi
Nakamura, Hiroyuki
author_facet Fujiwara, Shigeyoshi
Nakamura, Hiroyuki
author_sort Fujiwara, Shigeyoshi
collection PubMed
description SIMPLE SUMMARY: Chronic active Epstein–Barr virus (EBV) infection (CAEBV) is a rare syndrome of unknown etiology characterized by prolonged infectious mononucleosis-like symptoms and proliferation of EBV-infected T and/or natural killer cells. CAEBV has been primarily reported in East Asia and Latin America, suggesting a genetic predisposition in its pathogenesis. The clinical course of CAEBV is heterogeneous ranging from an indolent and occasionally self-limiting disease to an aggressive and fatal condition, but its prognosis is generally poor. This heterogeneous clinical picture does not suggest a simple etiology for the syndrome. Clinicopathological investigations of CAEBV suggest that it has aspects of both malignant neoplasm and immunodeficiency. This article summarizes the latest findings on CAEBV and discusses critical unsolved questions regarding its pathogenesis and disease concept. ABSTRACT: Chronic active Epstein–Barr virus (EBV) infection (CAEBV) is a rare syndrome characterized by prolonged infectious mononucleosis-like symptoms and elevated peripheral blood EBV DNA load in apparently immunocompetent persons. CAEBV has been primarily reported in East Asia and Latin America, suggesting a genetic predisposition in its pathogenesis. In most cases of CAEBV, EBV induces proliferation of its unusual host cells, T or natural killer (NK) cells. The clinical course of CAEBV is heterogeneous; some patients show an indolent course, remaining in a stable condition for years, whereas others show an aggressive course with a fatal outcome due to hemophagocytic lymphohistiocytosis, multiple organ failure, or progression to leukemia/lymphoma. The pathogenesis of CAEBV is unclear and clinicopathological investigations suggest that it has aspects of both malignant neoplasm and immunodeficiency. Recent genetic analyses of both viral and host genomes in CAEBV patients have led to discoveries that are improving our understanding of the nature of this syndrome. This article summarizes the latest findings on CAEBV and discusses critical unsolved questions regarding its pathogenesis and disease concept.
format Online
Article
Text
id pubmed-7692233
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76922332020-11-28 Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both? Fujiwara, Shigeyoshi Nakamura, Hiroyuki Cancers (Basel) Review SIMPLE SUMMARY: Chronic active Epstein–Barr virus (EBV) infection (CAEBV) is a rare syndrome of unknown etiology characterized by prolonged infectious mononucleosis-like symptoms and proliferation of EBV-infected T and/or natural killer cells. CAEBV has been primarily reported in East Asia and Latin America, suggesting a genetic predisposition in its pathogenesis. The clinical course of CAEBV is heterogeneous ranging from an indolent and occasionally self-limiting disease to an aggressive and fatal condition, but its prognosis is generally poor. This heterogeneous clinical picture does not suggest a simple etiology for the syndrome. Clinicopathological investigations of CAEBV suggest that it has aspects of both malignant neoplasm and immunodeficiency. This article summarizes the latest findings on CAEBV and discusses critical unsolved questions regarding its pathogenesis and disease concept. ABSTRACT: Chronic active Epstein–Barr virus (EBV) infection (CAEBV) is a rare syndrome characterized by prolonged infectious mononucleosis-like symptoms and elevated peripheral blood EBV DNA load in apparently immunocompetent persons. CAEBV has been primarily reported in East Asia and Latin America, suggesting a genetic predisposition in its pathogenesis. In most cases of CAEBV, EBV induces proliferation of its unusual host cells, T or natural killer (NK) cells. The clinical course of CAEBV is heterogeneous; some patients show an indolent course, remaining in a stable condition for years, whereas others show an aggressive course with a fatal outcome due to hemophagocytic lymphohistiocytosis, multiple organ failure, or progression to leukemia/lymphoma. The pathogenesis of CAEBV is unclear and clinicopathological investigations suggest that it has aspects of both malignant neoplasm and immunodeficiency. Recent genetic analyses of both viral and host genomes in CAEBV patients have led to discoveries that are improving our understanding of the nature of this syndrome. This article summarizes the latest findings on CAEBV and discusses critical unsolved questions regarding its pathogenesis and disease concept. MDPI 2020-10-30 /pmc/articles/PMC7692233/ /pubmed/33143184 http://dx.doi.org/10.3390/cancers12113202 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fujiwara, Shigeyoshi
Nakamura, Hiroyuki
Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
title Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
title_full Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
title_fullStr Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
title_full_unstemmed Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
title_short Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
title_sort chronic active epstein–barr virus infection: is it immunodeficiency, malignancy, or both?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692233/
https://www.ncbi.nlm.nih.gov/pubmed/33143184
http://dx.doi.org/10.3390/cancers12113202
work_keys_str_mv AT fujiwarashigeyoshi chronicactiveepsteinbarrvirusinfectionisitimmunodeficiencymalignancyorboth
AT nakamurahiroyuki chronicactiveepsteinbarrvirusinfectionisitimmunodeficiencymalignancyorboth